Tohda Y, Haraguchi R, Kubo H, Muraki M, Fukuoka M, Nakajima S
Fourth Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.
Methods Find Exp Clin Pharmacol. 1999 Jul-Aug;21(6):449-52. doi: 10.1358/mf.1999.21.6.541927.
In recent years, bronchial asthma has come to be regarded pathologically as a chronic inflammatory disease of the respiratory tract. Inhalational steroids and antiinflammatory drugs are recognized as being effective against bronchial asthma. In this study, the effects of Saiboku-to, a Chinese herbal (Kampo) formulation, were investigated on asthmatic guinea pigs sensitized to ovalbumin (OA). Following 7-day administration of Saiboku-to (500 micrograms/kg), the late asthmatic response (LAR) to an antigen challenge was found to be inhibited. The number of eosinophils in fluid obtained by bronchoalveolar lavage (BAL) 4 h after antigen challenge was decreased while the infiltration of eosinophils and T-lymphocytes into the lung parenchyma was inhibited. These findings suggest that Saiboku-to has the potential to become a useful drug in the treatment of bronchial asthma.
近年来,支气管哮喘在病理学上已被视为一种呼吸道慢性炎症性疾病。吸入性类固醇和抗炎药物被认为对支气管哮喘有效。在本研究中,对卵清蛋白(OA)致敏的哮喘豚鼠研究了汉方药柴朴汤的作用。给予柴朴汤(500微克/千克)7天后,发现抗原激发后的迟发性哮喘反应(LAR)受到抑制。抗原激发4小时后支气管肺泡灌洗(BAL)获得的液体中嗜酸性粒细胞数量减少,同时肺实质中嗜酸性粒细胞和T淋巴细胞的浸润受到抑制。这些发现表明,柴朴汤有潜力成为治疗支气管哮喘的有效药物。